Tag: Food and Drug Administration
Right-to-Try Law Signed!

On May 30, President Trump signed a bill into law allowing terminally ill patients access to potentially lifesaving drugs before they are approved by the Food and Drug Administration.

Curing Diseases Is Sustainable, Government in Healthcare Is Not

While Americans have every reason to be concerned about their healthcare, the belief that private medical companies will not develop and produce products that cure various conditions is unwarranted.

FDA Cracks Down on Online Eye-Exam Company

This past October, the Food and Drug Administration issued a warning letter to Opternative, a company specializing in providing online eye-exams.

The FDA Plans to Regulate Nicotine in Cigarettes

How likely are smokers to quit or cut back once nicotine levels decrease?

American Patients Can Access Far More New Cancer Drugs than Others Can

New research by scholars at the University of Pittsburgh shows that American patients have significantly better access to new cancer medicines than their peers in other developed countries: Of 45 anticancer drug indications approved in the United States between January 1, 2009, and December 31, 2013, 64% (29) were approved by the European Medicines…
Read More »

Congress Just Punched a Big Hole in Obamacare

President Obama signed the 21st Century Cures Act on December 13. Promoted as a pro-innovation bill, the new law will improve the Food and Drug Administration’s regulatory processes; as well as fund Vice-President Biden’s Cancer Moonshot, the National Institutes of Health, and steps to reduce the opioid epidemic. However, the final version of the…
Read More »

The FDA Cannot Hire Staff with Starting Salaries of $160,000

Would a starting salary of just above $160,000 turn you off? Well, maybe if you had a scientific PhD and had to wait four months before the employer could decide whether to hire you or not, you would find a spot elsewhere. This is the situation the Food and Drug Administration finds itself in,…
Read More »

Good and Bad News on Generic Drug Approvals

A solution to expensive patented medicines is generic competitors. The United States has struck a pretty good balance between innovation and low prices through the Hatch-Waxman (1984) Act, which specified patent terms for newly invented medicines, and a pathway for generic competitors to enter the market after a period. One obstacle to generic entry…
Read More »

Who Benefits from “Right to Try” Laws?

The Goldwater Institute has had great success getting states to pass “Right to Try” laws. Right to Try allows a desperately sick patient to take an experimental new medicine before the FDA has approved it. Since I last wrote about this in May 2014, 31 states have passed Right to Try. Further, U.S. Senator…
Read More »

One Solution to the EpiPen Crisis: Repeal Durham-Humphrey!

Posturing politicians on Capitol Hill conducted a hearing a few days ago during which they grilled Heather Bresch, CEO of Mylan N.V., maker of EpiPens. Prices of EpiPens have skyrocketed in the past few years (which I have discussed here and here). The politicians were more interested in wagging their fingers and tut-tutting at…
Read More »

  • Catalyst
  • MyGovCost.org
  • FDAReview.org
  • OnPower.org
  • elindependent.org